Location: Palo Alto, CA
CIK: 0001839948 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value: $1.023B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CGON | CG ONCOLOGY INC | 3,670,206 | $105M | 10.3% | $40.67 | -15.9% | COMM | 156944100 |
| DYN | DYNE THERAPEUTICS INC | 2,650,150 | $62.44M | 6.1% | $16.62 | +78.0% | COMM | 26818M108 |
| XNCR | XENCOR INC | 2,452,138 | $56.35M | 5.5% | $18.82 | +22.1% | COMM | 98401F105 |
| COGT | COGENT BIOSCIENCES INC | 6,964,375 | $54.32M | 5.3% | $9.05 | +10.1% | COMM | 19240Q201 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 2,890,816 | $48.42M | 4.7% | $7.22 | — | ADRS | 152309100 |
| OCUL | OCULAR THERAPEUTIX INC | 5,319,148 | $45.43M | 4.4% | $7.10 | +37.5% | COMM | 67576A100 |
| UPB | UPSTREAM BIO INC | 2,801,763 | $44.86M | 4.4% | $22.33 | 0.0% | COMM | 91678A107 |
| ABVX | ABIVAX SA AMERICAN DEPOSITARY SHARES | 6,056,596 | $44.33M | 4.3% | $12.76 | — | ADRS | 00370M103 |
| SVRA | SAVARA INC | 12,362,205 | $37.95M | 3.7% | $3.73 | -6.6% | COMM | 805111101 |
| TNGX | TANGO THERAPEUTICS INC | 10,736,000 | $33.17M | 3.2% | $4.64 | 0.0% | COMM | 87583X109 |
| DNTH | DIANTHUS THERAPEUTICS INC | 1,501,624 | $32.74M | 3.2% | $25.71 | 0.0% | COMM | 252828108 |
| IRON | DISC MEDICINE INC | 486,957 | $30.87M | 3.0% | $33.98 | +70.2% | COMM | 254604101 |
| MLYS | MINERALYS THERAPEUTICS INC | 2,470,265 | $30.41M | 3.0% | $12.35 | +5.9% | COMM | 603170101 |
| — | TOURMALINE BIO INC | 1,477,593 | $29.97M | 2.9% | $25.14 | — | COMM | 89157D105 |
| GPCR | STRUCTURE THERAPEUTICS INC | 1,063,000 | $28.83M | 2.8% | $43.45 | — | ADRS | 86366E106 |
| TYRA | TYRA BIOSCIENCES INC | 1,989,103 | $27.65M | 2.7% | $12.71 | +42.8% | COMM | 90240B106 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 3,572,335 | $26.61M | 2.6% | $10.51 | -11.4% | COMM | 30233G209 |
| — | Cidara Therapeutics, Inc. | 1,005,901 | $26.09M | 2.5% | $25.94 | — | COMM | 171757206 |
| — | THIRD HARMONIC BIO INC | 2,505,424 | $25.78M | 2.5% | $13.43 | — | COMM | 88427A107 |
| SLNO | SOLENO THERAPEUTICS INC | 550,000 | $24.72M | 2.4% | $47.87 | +8.2% | COMM | 834203309 |
| — | ASTRIA THERAPEUTICS INC | 2,761,861 | $24.69M | 2.4% | $14.07 | — | COMM | 04635X102 |
| FULC | FULCRUM THERAPEUTICS INC | 5,250,000 | $24.68M | 2.4% | $7.42 | -50.3% | COMM | 359616109 |
| SLN | SILENCE THERAPEUTICS PLC | 3,033,560 | $20.87M | 2.0% | $14.21 | — | ADRS | 82686Q101 |
| — | RAPT Therapeutics, Inc. | 13,135,260 | $19.75M | 1.9% | $1.50 | — | COMM | 75382E109 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 4,643,812 | $17.55M | 1.7% | $2.25 | +109.3% | COMM | 03237H101 |
| CMPS | COMPASS PATHWAYS LTD | 3,858,000 | $14.58M | 1.4% | $7.40 | — | ADRS | 20451W101 |
| KURA | KURA ONCOLOGY INC | 1,423,642 | $12.4M | 1.2% | $14.54 | -1.1% | COMM | 50127T109 |
| MBX | MBX BIOSCIENCES INC | 650,000 | $11.98M | 1.2% | $22.87 | -6.8% | COMM | 55287L101 |
| KOD | KODIAK SCIENCES INC | 1,145,538 | $11.4M | 1.1% | $4.16 | +38.1% | COMM | 50015M109 |
| TRDA | ENTRADA THERAPEUTICS INC | 584,955 | $10.11M | 1.0% | $17.12 | — | COMM | 29384C108 |
| KROS | KEROS THERAPEUTICS INC | 550,000 | $8.707M | 0.9% | $59.30 | -12.4% | COMM | 492327101 |
| — | ADVERUM BIOTECHNOLOGIES INC | 1,796,482 | $8.39M | 0.8% | $7.02 | — | COMM | 00773U207 |
| VTGN | VISTAGEN THERAPEUTICS INC | 2,676,580 | $7.896M | 0.8% | $3.41 | -17.5% | COMM | 92840H400 |
| — | AEROVATE THERAPEUTICS INC | 2,240,809 | $5.938M | 0.6% | $15.50 | — | COMM | 008064107 |
| — | NEKTAR THERAPEUTICS | 4,000,000 | $3.72M | 0.4% | $0.93 | — | COMM | 640268108 |
| AVTX | AVALO THERAPEUTICS INC | 483,000 | $3.589M | 0.4% | $10.31 | +3.7% | COMM | 05338F306 |
| VTYX | VENTYX BIOSCIENCES INC | 316,195 | $692K | 0.1% | $29.94 | -92.4% | COMM | 92332V107 |
| CABA | CABALETTA BIO INC | 86,795 | $197K | 0.0% | $3.64 | -3.6% | COMM | 12674W109 |